Medigus: ScoutCam Announces Upgrade to OTCQB Venture Market

Medigus: Fortune 500 Multinational Healthcare Corporation’s Adds ScoutCam to its Approved Supplier List

Medigus Announces Six Months Financial Results

Medigus to Enter Online Brands Marketing on Amazon Marketplace

Medigus Signs a non-binding letter of intent to acquire a controlling interest of two companies which operate as sellers of three brands on Amazon Marketplace

Medigus: ScoutCam Announced Acceptance of $2.4M Quote from a Fortune 500 Multinational Healthcare Corporation

Following Acceptance of $2.4M Quote, Preeminent Visual Solutions Creator will Develop Customized Products for Medical Supplies Giant

Medigus to Resell Polyrizon’s Future Products for Protection Against COVID-19 Spread and Other Biological Threats

GERD IP, A Subsidiary of Medigus, Files Complaint with Delaware District Court Alleging Infringement of two Proprietary Patents

Medigus Increases Holdings in ScoutCam

The Company Increased its Ownership in ScoutCam to 50.1% Following the Conversion of Credit into Equity

Medigus: ScoutCam Granted Canadian Patent for New Endoscope Irrigation Technology

Medigus Ltd. Announces Closing of $5 Million Public Offering

Medigus: ScoutCam Achieved Breakthrough with Healthcare’s First of its kind OR-Ready Wireless Endoscope

Medigus Ltd. Announces Pricing of $5 Million Public Offering

Medigus (MDGS) Subsidiary ScoutCam receives $2 million investment from Mori Arkin

Medigus Announces Proposed Public Offering

Medigus Signed an Exclusive Agreement with Elbit Systems Land for the Distribution in Mexico of Pandemic Response Ventilators for COVID-19 Patients

Polyrizon Filed a US Patent Application for Formulations and Methods for Preventing Viral Infections by COVID-19 Virus

Medigus Signs a Collaboration Agreement with L1 Systems for the Commercialization of COVID-19 Medical Products and Solutions

ScoutCam Receives a $500,000 Purchase Order for its Micro Cameras from a Fortune 500 Multinational Healthcare Corporation

Medigus Signed a Binding Letter of Intent with Polyrizon for an Investment in and Joint Commercialization of Biological Gels for Protecting Patients against COVID-19 and Other Biological Threats

Medigus Ltd. Announces 2019 Financial Results